Ray Co., Ltd. (KOSDAQ:228670)
South Korea · Delayed Price · Currency is KRW 5,410.00
-90.00 (-1.64%)
Oct 10, 2025, 3:30 PM KST
Ray Co., Ltd. Market Cap
Ray Co., Ltd. has a market cap or net worth of 84.41 billion as of October 10, 2025. Its market cap has decreased by -35.99% in one year.
Market Cap
84.41B
Enterprise Value
143.06B
Revenue
89.70B
Ranking
n/a
PE Ratio
n/a
Stock Price
5,410.00
Market Cap Chart
Since August 8, 2019, Ray Co., Ltd.'s market cap has decreased from 164.67B to 84.41B, a decrease of -48.74%. That is a compound annual growth rate of -10.29%.
Market Cap History
| Date | Market Cap | % Change |
|---|---|---|
| Oct 2, 2025 | 85.81B | -4.96% |
| Dec 30, 2024 | 90.29B | -74.15% |
| Dec 28, 2023 | 349.24B | 7.23% |
| Dec 29, 2022 | 325.68B | -13.67% |
| Dec 30, 2021 | 377.24B | 6.38% |
| Dec 30, 2020 | 354.62B | 24.24% |
| Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
| Aug 8, 2019 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
| Company | Market Cap |
|---|---|
| Samsung Biologics | 72.17T |
| Celltrion | 38.24T |
| ALTEOGEN | 24.66T |
| Yuhan | 8,969.60B |
| SK Biopharmaceuticals | 8,136.75B |
| Peptron | 6,866.96B |
| PharmaResearch | 5,631.19B |
| LigaChem Biosciences | 5,545.53B |